MKI67 and COVID-19: In COVID-19 patients, NK cells expressing these lung-homing receptors displayed higher expression of CD69 (on CD56brightCD16– and CD56dimCD16+ NK cells) and Ki67 (in CD56dimCD16+), as compared to lung-homing receptor-negative NK cells (Figures 2A–C).